Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors

BACKGROUND: Multiple myeloma (MM) is still a fatal plasma cell cancer. Novel compounds are currently clinically tested as a single agent in relapsing patients, but in best cases with partial response of a fraction of patients, emphasising the need to design tools predicting drug efficacy. Histone de...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Moreaux, J, Reme, T, Leonard, W, Veyrune, J-L, Requirand, G, Goldschmidt, H, Hose, D, Klein, B
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2013
Konular:
Translational Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3739014/
https://ncbi.nlm.nih.gov/pubmed/23868005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.392
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller